Navigation path

HIV / AIDS Projects

List of HIV / AIDS projects sorted by Acronym

no acronym Collaboration on Vaginal Microbicides Development for the Prevention of HIV Transmission
ADVAC-EC Advanced Vaccinology Training for Scientists from ACC and Developing Countries: From Genomics to Vaccination Strategies for Communicable Diseases Linked to Poverty
AIDS-CoVAC Generation of a Coronavirus-Based Multigene AIDS Vaccine and Evaluation in a Preclinical SIV model
Allomicrovac A combined microbicidal-immunizing strategy against SIV and HIV infection
Auto/AlloCell-HIV Development of a Novel Therapeutic HIV-1 Vaccine: Horizontal Gene Transfer by Using Apoptotic HIV-1 DNA Containing Activated T-cells
AVIP Aids Vaccine Integrated Project
Bridging gaps Bridging the Gaps Between Public and Traditional Healthcare Sectors – Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa
CASA Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings
CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe
CASCADE Concerted Action on SeroConversion to AIDS and Death in Europe
CASCADE Virology Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe
CHAARM Combined Highly Active Anti-retroviral Microbicides
China-HIV-VacIII Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China
CTL and HIV- super Infection CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection
CUT’HIVAC Cutaneous and Mucosal HIV Vaccination
DEC-VAC Development of a Dendritic Cell-targeted Vaccine against AIDS
DETEC SIV/HIV Vaccines: Detecting Efficacy and Explaining Inefficacy
DETECTHIV Sensitive Nanoparticle Assay For the Detection of HIV
ECS European Collaborative Study on Pregnant HIV Infected Women and Their Children
EDCTP European and Developing Countries Clinical Trials Programme
EMPRO European Microbicides project
ENVEP European Network for Vaccine Evaluation in Primates: Combined Vector Immunisation for AIDS Vaccine Development
EPI-VAC Identification of Novel Epitopes as HIV-1 Vaccine Candidates
EPIVAC Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS
EuropeHIVResistance European Cohort Coordinating Network on HIV Drug Resistance
EuroCoord European network of HIV/AIDS cohort studies to coordinate at European and International level clinical research on HIV/AIDS
EuroSIDA The EuroSIDA network 2000-200: Clinical and Virological Outcome of European Patients Infected with HIV
EuroSIDA 2005-2009 The EuroSIDA Network 2005-2009 – Clinical and Virological Outcome of Patients with HIV under Care in Europe
EUROPRISE European Vaccines and Microbicides Enterprise
EUROVAC I European Vaccine Effort Against HIV/AIDS
EUROVAC II European Vaccine Effort Against HIV/AIDS-II
EuroVac-III European Vaccine Effort Against HIV/AIDS – III
EVA Programme EVA (European Vaccine Against Aids) Centralised Facility For Aids Reagents
ExCellENT-HIT Exploiting Cellular Transport of Nuclear Transcripts as HIV Innovative Therapy
GISHEAL Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors
HIDDEN HIV CHALLENGE Challenging the Hidden HIV: Understanding the Block on Transcriptional Reactivation to Eradicate Infection
HIV COM THER Development and Testing of a Combined Anti-Retroviral, Immune, and Gene Therapy for Treatment of HIV Patients
HIV PI resistance HIV protease inhibitor resistance by enzyme- substrate coevolution
HIV PR INHIBITORS Rational Approaches Towards Understanding and Overcoming HIV Protease Inhibitor Resistance
HIVResInh Preparation and Identification of New HIV Reverse Transcriptase Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS drugs
HIV RESISTANCE New Tools to Investigate and Suppress HIV Drug Resistance
HIVSTOP Development of an Effective RNA Interference-Based Anti-HIV-1 Therapy Using an SV40-Derived Vector
HIV VIROSOMES Development of a New Vaccine Against HIV: Virosomes Incorporating HIV proteins
HIVAB Generation of Broadly Cross Neutralising Antibodies for Innovative Active-passive HIV Vaccination Strategies Based on Modified Ig-gene Transgenic Mice
HIVIS Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study
HIVPRIMEBOOST THERVAC Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen
HIV-superinfections Behavioural, Immunological and Virologic Correlates of HIV-1 Superinfection (HIV+ vs HIV++) in Rural Tanzania
MILD-TB Immunogenicity of Mycobacterium Tuberculosis lipids in the Non Replicating Status of latency
MUNANO VAC Mucosal Nano Vaccine Candidate for HIV
MUVADEN Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells
MUVAPRED Mucosal Vaccines for Poverty Related Diseases
NeutNet Standardisation of HIV Neutralisation Assays to be Used in Vaccine Research and Clinical Trials
NEAT The European AIDS Treatment Network
New cAMP antagonists Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy
NEWHIVTARGETS Identifying novel classes of HIV inhibitors
ORISS Project Operational Research in STI and Related Services for Women in High-Risk Situations in Cambodia and Thailand
PENTA Paediatric European Network for the Treatment of AIDS
PENTA/ECS Paediatric European Network for Treatment of AIDS and European Collaborative Study on HIV-infected pregnant women and their children
PHARMA-PLANTA Recombinant Pharmaceuticals from Plants for Human Health
Pox-gene A Combined Pox-virus/Lentiviral Vector System to Treat HIV Infection; Immunisation and Direct In Vivo Gene Transfer in T-Lymphocytes
RMVHIV Recombinant Measles Virus as a Vector for HIV Vaccines
SATZ Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa
SHIVA Selection and Development of Microbicides for Mucosal Use to Prevent Sexual HIV Transmission/Acquisition
SPREAD Strategy to Control SPREAD of HIV Drug Resistance
TARGETING NEF The HIV-1 Pathogenicity Factor Nef as a Novel Therapeutic Target
TBIRIS Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART
Teach CD4 International CD4 T-Lymphocyte Training Programme for the Support of HIV Clinical Trials Networks
THERAVAC Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac
TIP-VAC Explaining and Improving Efficacy of Targeted Immunodeficiency Virus-like Particle Vaccines against AIDS
TRIoH Targeting Replication and Integration of HIV
UNITE-MORE Uniformity in Testing and Monitoring HIV Resistance
VaccTIP Vaccine Strategies for Combined Targeting of Innate and Adaptive Immune Pathways
VIAV Very Innovative AIDS Vaccine
VirApt Antiviral Aptamers for Treatment of HIV-1 Infection
VIRULENCE HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence